摘要
内吞起源的细胞外囊泡(EVs)被称为外来体。 这些囊泡由细胞释放,存在于生物流体中,例如唾液,尿液和血浆。 这些囊泡由小RNA,DNA,蛋白质组成,在许多生理过程中起着至关重要的作用。 在中枢神经系统(CNS)中,它们参与各种生理过程,例如神经细胞的应激,细胞之间的通讯,突触可塑性和神经发生。 外泌体在抑郁症中的作用有待进一步探讨。 已知外泌体可以穿过由神经胶质细胞星形胶质细胞组成的血脑屏障(BBB)。 这些囊泡的优势之一是它们能够将大分子(如DNA,蛋白质,mRNA和miRNA)转移至受体细胞。 这篇综述集中在外泌体在抑郁症中的潜在作用及其作为抑郁症的治疗选择或诊断工具的利用。
关键词: 抑郁症,外来体,血脑屏障,血清素,生物标志物,氧化应激。
图形摘要
Current Drug Targets
Title:Exosomes: A Novel Therapeutic Paradigm for the Treatment of Depression
Volume: 22 Issue: 2
关键词: 抑郁症,外来体,血脑屏障,血清素,生物标志物,氧化应激。
摘要: Extracellular vesicles (EVs) of endocytic origin are known as exosomes. These vesicles are released by cells and are found in biofluids, such as saliva, urine, and plasma. These vesicles are made up of small RNA, DNA, proteins, and play a vital role in many physiological processes. In the central nervous system (CNS), they participate in various physiological processes such as stress of nerve cells, communication between the cells, synaptic plasticity, and neurogenesis. The role of exosomes in depression needs to be explored further. It is known that exosomes can cross the blood brain barrier (BBB), which is made up of glial cells astrocytes. One of the advantages of these vesicles is that they are able to transfer macromolecules like DNA, protein, mRNAs, and miRNAs to recipient cells. This review focuses on the potential role of exosomes in depression and their utilization as a treatment option or diagnostic tool of depression.
Export Options
About this article
Cite this article as:
Exosomes: A Novel Therapeutic Paradigm for the Treatment of Depression, Current Drug Targets 2021; 22 (2) . https://dx.doi.org/10.2174/1389450121999201006193005
DOI https://dx.doi.org/10.2174/1389450121999201006193005 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Update on Eosinophilic Lung Diseases and Anti-IL-5 Treatment
Recent Patents on Anti-Infective Drug Discovery Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Current Vascular Pharmacology Cocaine and Acute Vascular Diseases
Current Drug Abuse Reviews Recent Progress of Machine Learning in Gene Therapy
Current Gene Therapy Inhibitors of Nitrogen Oxide Species Production in Animal Models of Inflammation and Future Directions for Therapy in Inflammatory Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Selective Elevation of Circulating CCL2/MCP1 Levels in Patients with Longstanding Post-vaccinal Macrophagic Myofasciitis and ASIA
Current Medicinal Chemistry Biological Agents in Familial Mediterranean Fever Focusing on Colchicine Resistance and Amyloidosis
Current Medicinal Chemistry Nitric Oxide Synthase and Cyclooxygenase Pathways: A Complex Interplay in Cellular Signaling
Current Medicinal Chemistry Pembrolizumab-Induced Seronegative Arthritis and Fasciitis in a Patient with Lung Adenocarcinoma
Current Drug Safety Cardiovascular Magnetic Resonance for Evaluation of Heart Involvement in ANCA-Associated Vasculitis. A Luxury or a Valuable Diagnostic Tool?
Inflammation & Allergy - Drug Targets (Discontinued) Myocardial Infarction. Pathological Relevance and Relationship with Coronary Risk Factors
Current Pharmaceutical Design Herpetic (Non-Cytomegalovirus) Retinal Infections in Patients with the Acquired Immunodeficiency Syndrome
Current HIV Research Pathophysiology of Myocardial Infarction and Acute Management Strategies
Cardiovascular & Hematological Agents in Medicinal Chemistry Immunomodulation in Inflammatory Neuropathies: Rationale and Safety
Current Drug Safety Haptoglobin Polymorphism and Lacunar Stroke
Current Neurovascular Research The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Cardiovascular Pharmacogenetics of Antihypertensive and Lipid- Lowering Therapies
Current Molecular Medicine APOC-III Antisense Oligonucleotides: A New Option for the Treatment of Hypertriglyceridemia
Current Medicinal Chemistry Editorial: New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations
Current Drug Targets